Minitran



Indications and Reactions:

Role Indications Reactions
Primary
Blood Pressure Increased 14.3%
Bone Density Abnormal 14.3%
Coronary Artery Disease 14.3%
Face Lift 14.3%
Muscle Strain 14.3%
Myocardial Infarction 14.3%
Product Used For Unknown Indication 14.3%
Application Site Reaction 12.5%
Cardiac Arrest 12.5%
Cerebrovascular Accident 12.5%
Coronary Artery Bypass 12.5%
Fall 12.5%
Posterior Reversible Encephalopathy Syndrome 12.5%
Subcutaneous Abscess 12.5%
Thermal Burn 12.5%
Secondary
Drug Use For Unknown Indication 26.3%
Hypertension 15.8%
Myocardial Ischaemia 10.5%
Pulmonary Hypertension 10.5%
Atrial Fibrillation 7.9%
Product Used For Unknown Indication 7.9%
Hypothyroidism 5.3%
Angina Pectoris 2.6%
Cardiovascular Event Prophylaxis 2.6%
Dementia Alzheimer's Type 2.6%
Depression 2.6%
Gastrooesophageal Reflux Disease 2.6%
Osteoporosis 2.6%
Hypotension 33.3%
Diabetes Mellitus 20.0%
Drug Hypersensitivity 13.3%
Bradyarrhythmia 6.7%
Bradycardia 6.7%
Insomnia 6.7%
Syncope 6.7%
Urticaria 6.7%
Concomitant
Product Used For Unknown Indication 31.9%
Drug Use For Unknown Indication 20.2%
Hypertension 10.4%
Atrial Fibrillation 5.1%
Diabetes Mellitus 4.0%
Cardiac Disorder 3.6%
Myocardial Ischaemia 3.1%
Pain 3.0%
Thrombosis Prophylaxis 2.6%
Prophylaxis 2.4%
Angina Pectoris 2.1%
Cardiac Failure Chronic 1.7%
Depression 1.6%
Breast Cancer 1.4%
Chest Pain 1.4%
Systemic Sclerosis 1.4%
Major Depression 1.1%
Cardiac Failure 1.0%
Osteoporosis 1.0%
Rheumatoid Arthritis 1.0%
Myocardial Infarction 11.1%
Vomiting 8.3%
Weight Decreased 8.3%
Pulmonary Oedema 7.4%
Thrombocytopenia 7.4%
Anaemia 6.5%
Syncope 6.5%
Drug Interaction 4.6%
Therapeutic Agent Toxicity 4.6%
Type 2 Diabetes Mellitus 4.6%
Renal Failure 3.7%
Skin Exfoliation 3.7%
Urinary Incontinence 3.7%
Aplasia Pure Red Cell 2.8%
Bladder Cancer 2.8%
Cardiac Arrest 2.8%
Cardiac Failure 2.8%
Fall 2.8%
Heart Rate Increased 2.8%
Pain 2.8%
Interacting
Hypertension 28.6%
Myocardial Ischaemia 28.6%
Prophylaxis 28.6%
Atrial Fibrillation 14.3%
Drug Interaction 33.3%
Hyperkalaemia 33.3%
Neuropathy Peripheral 33.3%